Global Commercial Oncology CDx Lead

ROLE SUMMARY

At Pfizer Oncology, we are committed to “Outdo Cancer” by advancing transformative medicines wherever we can make a profound difference in the lives of patients. Today, Pfizer Oncology has an industry-leading pipeline that includes the combined legacy Pfizer and Seagen portfolio across breast, genitourinary, hematology-oncology, thoracic and gastrointestinal therapeutic areas. 

The Global Commercial Oncology CDx Lead will drive commercial thought leadership on companion diagnostic global launch strategy for pre-launch oncology assets, including a potential first-in-class integrin-Beta-6 (IB6)-targeting antibody drug conjugate (ADC) sigvotatug vedotin (SV) (should a companion diagnostic be needed).  The first commercial launch could potentially be in 2L+ NSCLC in 2027.

The role requires demonstrated experience harmonizing commercial companion diagnostics global launch excellence and Rx launch strategy. Specific experience in global marketing, commercial strategy, market development and alliance management are core to the experience set.

ROLE RESPONSIBILITIES

• Lead the development and execution of global commercial companion diagnostic (CDx) launch strategies that are well-aligned with Rx launch strategies
• Develop and implement global market development plans to drive awareness of testing and adoption of new companion diagnostic solutions, including education, awareness, and stakeholder engagement.
• Lead and manage commercial diagnostic global partnerships to ensure aligned commercial strategies and joint value propositions for CDx and Rx; oversee joint steering committees
• Partner with Oncology R&D Clinical Diagnostics, Clinical Development, Global Medical Affairs, Regulatory, and Global Access & Value teams to ensure seamless incorporation of CDx commercial considerations into clinical development plans
• Partner with US and International commercial teams and Commercial Strategy & Innovation (CSI) to ensure alignment on target product profiles that may incorporate biomarker-selected populations, and global revenue assumptions on biomarker testing
• Deliver Global Guidance for Operating Plan and Long-Range Forecast assumptions for brands that require biomarker testing (i.e., global testing rates, HCP actionability rates) reflective of CDx aspiration as well as risk/benefit to medicine uptake by leveraging real world data
• Drive integration of CDx into specific tumor area treatment ecosystems to optimize patient identification and access to targeted therapies
• Work closely with Global Access & Value team and regional teams to support reimbursement strategies and health technology assessments for CDx.
• Identify and address barriers to CDx uptake, including logistical, operational, and economic challenges.
• Partner with Oncology Customer Analytics & Insights (CAI) to establish standardized KPIs and performance metrics to measure success of CDx initiatives globally.
• Develop detailed, strategic commercialization roadmaps and plans to ensure CDx launch readiness and appropriate planning assessments by partnering closely with the Chief Marketing Office Launch Excellence team.
• Build and maintain relationships with key external stakeholders, including diagnostic companies, healthcare providers, patient advocacy groups, and payers.
• Monitor global market trends, regulatory landscapes, and competitive intelligence to inform strategic decisions and anticipate future needs.
• Conduct all activities and make decisions that are in accordance with Company policies and SOPs, Pfizer Values & global regulatory guidelines, and requests consultation when navigating uncertain situations.

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.

• Bachelor’s degree
• 12+ years of commercial experience in the pharmaceutical industry
• Demonstrated experience and expertise leading and executing a successful global pharmaceutical/biotech oncology companion diagnostic launch
• Ability to work independently across senior level stakeholders and demonstrates judgement of what needs to be escalated
• Strong team player with demonstrated ability to engage experts from a wide range of functional areas to improve business performance and find a path forward
• Strong strategic thinking, analytical skills, detail and action oriented, creative, flexible, self-motivated
• Proven track record of translating key insights into meaningful strategies and tactics
• Excellent verbal and written communication skills